JPAS - Illiquid Assets LLC - Life Sciences 2022 Series — Form D/A
JPAS - Illiquid Assets LLC - Life Sciences 2022 Series of San Francisco, CA, a pooled investment fund, filed a Form D amendment with the SEC on 2022-09-23. $31.2M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2022-09-23
- Form: D/A
- Accession: 0001501011-22-000005
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $31.2M
- Minimum investment: $10K
- Investors: 30
- Date of first sale: 2021-09-15
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-414397
Issuer
- Name: JPAS - Illiquid Assets LLC - Life Sciences 2022 Series
- CIK: 0001882653
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 100 Pine Street, Suite 2600, San Francisco, CA, 94111
- Phone: 415-417-3000
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Michel A Del Buono | Executive Officer | San Francisco, CA |
| Frank S Ghali | Executive Officer | San Francisco, CA |
| n/a Jordan Park Group LLC | Promoter | San Francisco, CA |
| Davie M Baccei | Executive Officer | San Francisco, CA |
| George H Lusch | Executive Officer | San Francisco, CA |
| Samantha R Brown | Executive Officer | San Francisco, CA |
| Heather H Brownlie | Executive Officer | New York, NY |
| Patrick J Dunne | Executive Officer | San Francisco, CA |
| Jennifer K Ciresi | Executive Officer | San Francisco, CA |
| David S Lee | Executive Officer | Corinth, MS |
Other filings by this issuer (2)
More